Supreme Court votes to allow ‘pay-for-delay’ generic drug deal challenges
The Supreme Court has ruled that deals made between pharmaceutical companies and their generic drug competition may be challenged.
The Supreme Court has ruled that deals made between pharmaceutical companies and their generic drug competition may be challenged.
Many hope for the passage of a measure that is aimed at reducing a U.S. shortage of generic drugs.
The Supreme Court has ruled that deals made between pharmaceutical companies and their generic drug competition may be challenged.
Many hope for the passage of a measure that is aimed at reducing a U.S. shortage of generic drugs.